← Issue №14/ week of Oct 4, 2026/IBD

Impact of advanced therapy initiation on antibiotic dependence in chronic pouchitis.

From GI Signals issue №14: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD retrospective · n=67 · Oct 1, 2026 · Inflamm Bowel Dis · IF 4.5

Impact of advanced therapy initiation on antibiotic dependence in chronic pouchitis.

New evidencepouchitisbiologicsanti-TNFvedolizumab
Clinical takeawayConsider anti-IL therapy for chronic pouchitis patients aiming to reduce antibiotic dependence, particularly in those with persistent antibiotic use despite other advanced therapies, while acknowledging that many patients may still require antibiotics.
What it found61% of patients on advanced therapies for chronic pouchitis had reduced antibiotic use, with anti-IL therapy associated with higher odds of reduction compared to other advanced therapies (adjusted OR 11.1; 95% CI, 2.12-57.62). However, 79% of prevalent AT users still required antibiotics.
ContextChallenges the current reliance on antibiotics for chronic pouchitis by suggesting advanced therapies, especially anti-IL agents, may reduce antibiotic dependence in select patients.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Pan Y … Ananthakrishnan AN · Inflammatory Bowel Diseases · IF 4.5 · PubMed ↗Permalink
← Read the whole of issue №14 Every paper GI Signals surfaces gets a page like this one. All issues